Introduction
Cigarette smoking contributes to coronary heart disease, myocardial infarction (MI) and cardiac death. Furthermore, persistent smoking after cardiac surgery has been consistently identified as a predictor of increased mortality in follow-up studies after cardiac surgery w1, 2x. It is therefore somewhat surprising that studies have reported conflicting results on the association between preoperative smoking status and outcomes from cardiac surgery w3x. Analysis limited to older populations suggests a stronger association between smoking and outcome in cardiac surgery w4, 5x. In the past, these conflicting bodies of evidence have contributed to inequalities in the availability of elective cardiac surgery to smokers w6x. We undertook an observational study to assess the effect of preoperative smoking status on in-patient outcomes following adult cardiac surgery at different ages. So as to eliminate the variable effect of smoking in ex-smokers (with differing periods of preoperative cessation), we limited the analysis to current smokers and never-smokers at the time of admission.
Materials and methods
Over a five-year period ending March 2007, details of all adult cardiac surgical patients admitted to the Freeman Hospital were collected in line with published national society guidelines (www.scts.org) using an electronic database (Patient Administration and Tracking System, Dendrite, London). The data collection process is subject to regular external audit. The data completeness in the study dataset was 97.3%.
During this period, all current smokers were identified. An equal number of never-smokers were chosen at random from the study period by the software. We analysed preoperative comorbidity, intraoperative factors and morbidity and mortality outcomes in the two groups. Consistent with the contemporaneous Central Cardiac Audit Database definitions, poor ejection fraction was defined as -30% on echocardiography. Pulmonary disease was defined as chronic obstructive pulmonary disease (COPD), emphysema or asthma requiring bronchodilator or steroid therapy or with forced expiratory volume in one second -75% predicted. Neurological disease referred to documented transient ischaemia attack, reversible ischaemic neurological deficit or cerebrovascular accident. Renal disease was defined as serum creatinine )200 mmolyl, a functioning renal transplant or dialysis. Dyspnoea status was defined according to the New York Heart Association classification and angina status according to the Canadian Cardiovascular Society grading scale. Pulmonary complications were defined as those resulting in re-intubationy ventilation or tracheostomy. Infections were recorded as septicaemia, urinary tract infection, chest or wound infection requiring treatment. New postoperative stroke and death referred to status at discharge.
Statistical analysis was undertaken using SAS (SAS, NC, USA). For univariate analysis, proportions were compared using x cross-tabulation or Fisher's exact test and contin-2 uous variables were compared using unpaired t-tests and the Mann-Whitney U-test as appropriate. Logistic regression was performed using a binary logit model in which the contribution of each of the demographic and comorbidity parameters to pulmonary complications were sequentially assessed. The criteria for entry into each successive stage of the model was a Wald x statistic equivalent to P-0.05. 
Results
Between April 2002 and March 2007, 5130 patients underwent cardiac surgery. Median age was 62.5"7.5 years and 67% were male. There were 554 current smokers, making up 10.8% of the total case-load. During the same period, 1452 patients were admitted for cardiac surgery who denied ever having smoked. From this group, a further 554 patients were selected at random. The study population of 1108 underwent coronary artery bypass graft (CABG) (63.4%), valve procedures (23.1%) combined CABGyvalve procedures (10.1%) and other procedures (3.4%).
There were important differences in the comorbidities of the current smokers and never-smokers ( Table 1) . The current smokers included more males (72.2 vs. 62.3%). They had had more MIs (45.1 vs. 29.9%) and there was an increased proportion of patients with poor ejection fraction (8.2 vs. 3.8%). More patients had pulmonary disease (19.7 vs. 9.6%), neurological disease (10.1 vs. 6.2%) and extracardiac arteriopathy (17.1 vs. 8.3%). A higher proportion of patients underwent CABG as their primary procedure (68.1 vs. 58.7) and less underwent valve-related procedures (27.4 vs. 18.8%).
As a group, the never-smokers had higher EuroSCOREs than the current smokers (4.71 vs. 4.26, Ps0.03), suggesting they were at increased overall risk of postoperative mortality w7x. After stratification by age, the EuroSCORE appears lower for non-smokers aged 50 years or under and higher for smokers above that age (Fig. 1) . Mean EuroSCORE of the elderly smokers who survived to discharge were only minimally higher than those who died. Overall in-patient mortality was 3.3%. This was slightly higher in the current smokers than the never-smokers (4.3 vs. 2.3%, Ps0.07). Amongst the current smokers, there were significantly higher rates of infection (31.8 vs. 22.0%, P-0.001), pulmonary complications (11.0 vs. 6.8%, Ps 0.01) and intensive therapy unit readmission (6.9 vs. 4.0%, Ps0.03, Table 2 ).
Stratification by age revealed markedly increased inpatient mortality in the current smokers aged over 70 years, as compared with the never-smokers (14.8 vs. 2.1%, Ps0.0001, Fig. 2 ).
Consistent with this, analysis of the over 70 years group revealed significantly higher levels of postoperative morbidity in the smokers when compared with the neversmokers (Table 3, Fig. 3 ). There were significantly increased rates of pulmonary complications (24.7 vs. 8.2%, Ps0.0002), new renal replacement therapy (17.3 vs. 3.1%, P-0.0001), and readmission to critical care (19.8 vs. 5.2%, Ps0.0002). There were significantly more infections (44.4 vs. 23.8%), of which chest infections accounted for 57.5%. The duration of postoperative ventilatory support and critical care stay were significantly longer.
Comparison of the levels of comorbidity between the current and never-smokers within the over 70-year-olds is shown in Table 4 . Statistically significant differences in ejection fraction, as well as rates of MI, pulmonary disease and extracardiac arteriopathy were also observed between the current and never-smokers aged 51-60 years and 61-70 years. Despite these disparate comorbidities, smoking was not associated with significant differences in outcome in these younger patients.
To further account for possible confounder bias, logistic regression of the predictors of operative mortality within the over 70-year-olds was attempted. Due to the small number of deaths in the never-smokers, however (ns4), a robust model could not be generated. Assessment of the predictors of postoperative pulmonary complications by the same multivariate method identified current smoking, height and operative type (elective vs. other) as significant factors (Table 5) .
Discussion
In the current analysis, the overall mortality of the smokers was comparable to that of the never-smokers but over the age of 70 years, they had markedly increased levels of in-patient mortality and morbidity. More than 20% of UK cardiac procedures are now performed on the over75s, making the outcomes of this group a growing priority (Sixth National Adult Cardiac Surgical Database Report, 2008, www.scts.org) .
Consistent with our data, the largest risk stratification studies have not shown smoking to be an independent predictor of operative mortality after cardiac surgery w7, 8x. These analyses did not, however, report the effect of smoking at different ages. It is noteworthy that in our Fig. 3 . Rate of pulmonary complications following cardiac surgery, categorised by smoking status and age group. population, the EuroSCORE was a good predictor of mortality in all but the elderly smokers.
In previous reports of patients undergoing CABG, preoperative smoking cessation resulted in a significant decrease in postoperative pulmonary complications. In one blinded prospective study, this finding remained significant when patients stopped smoking just two months before surgery (57.1 vs. 14.5%) w9x. In a larger retrospective study, current smokers had significantly higher rates of pulmonary complications than those who had stopped smoking for at least four weeks preoperatively w10x. In these analyses, smoking had no effect on in-patient mortality.
Others have rejected preoperative smoking status as a predictor of outcomes: a large retrospective study found smoking status to have no impact on in-patient morbidity or mortality w3x. In this analysis, however, patients were classified as either current smokers or non-smokers. Given that smokers are more likely to quit around the time of an operation for smoking-related disease, the non-smoking group is likely to have included a number of recently exsmokers w11x.
Studies of older populations undergoing cardiac surgery have reported smoking as an independent risk factor more consistently. In a multivariate analysis of over 70-year-olds undergoing internal mammary artery grafting, He et al. reported a history of smoking (current and ex-smokers were compared with never-smokers) as an independent predictor of in-patient mortality. Current smoking alone was associated with an increased mortality but this observation failed to reach significance w4x. In follow-up studies, analyses in older groups have identified smoking at the time of cardiac surgery as predictor of long-term survival w5, 12x.
In summary, previous analyses have produced conflicting evidence regarding the effect of smoking on the short-and long-term outcomes of cardiac surgery whilst studies of older populations have generated more consistent results. The current study reports on a complete adult cardiac surgical population in age-stratified subsets and smoking appears to have an effect on the outcomes of the older patients alone. These data may therefore help to resolve the discrepant findings of previous work.
The precise explanation for the apparent collaborative effect of smoking and increased age remains unclear. The cumulative effect of persistent cigarette smoking, partly mediated through the development of COPD, would seem the most likely explanation. Additionally, the older cardiac surgical population, with its attendant comorbidity, may suffer the injurious effects of smoking more profoundly.
In our population, the rate of pulmonary complications and operative mortality share common associations with increasing age and smoking status. Cross-tabulation of the elderly smokers who suffered both pulmonary complications and who also died goes further to support a possible link between these outcomes (x s4.6, Ps0.03). After logistic 2 regression, current smoking remained a predictor of postoperative pulmonary complications. The retention of short stature in this model may be explained by reported associations with both cardiac and respiratory disease w13, 14x.
Comparison of the current and never-smokers, both as a complete group and in the over 70-year-olds, reveals important differences in baseline cardiopulmonary comorbidity; these reach statistical significance over the age of 50 years. The effects of smoking on cardiopulmonary physiology are well understood and these differences are therefore predictable. It seems unlikely that these patterns of background disease, independent of smoking, would account for the observed differences in complication rates in the over 70-year-olds, but the current study was not powered to investigate this issue.
The limitations of the current study are therefore principally related to subset size after stratification by age: the small number of deaths in the older smokers precluded logistic regression to account for confounder bias. The comparable effects of smoking on several categories of morbidity as well as mortality in the older patients alone adds validity to the findings but a matched study design or multivariate analysis in larger sub-populations would allow firmer conclusions to be drawn.
In addition, there was no biochemical confirmation of smoking status. Polarising the population into current and never-smokers, however, would be expected to have categorised the population more accurately.
The current data strengthen the observation that preoperative smoking is predictive of adverse outcomes of cardiac surgery in the elderly, and pulmonary complications may exert a significant effect on outcome. The largest studies to assess the effect of smoking cessation before cardiac surgery support the benefit of even short-term cessation but the findings of these cannot be extrapolated to the elderly population w9, 10x. Further study into the effect of preoperative smoking cessation in the elderly may inform cessation counselling and the timing of surgery.
